Jerry S. Lanchbury - Jul 9, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Stock symbol
MYGN
Transactions as of
Jul 9, 2021
Transactions value $
-$430,735
Form type
4
Date filed
7/12/2021, 06:16 PM
Previous filing
Jul 8, 2021
Next filing
Jul 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $707K +26.7K +11.48% $26.49 259K Jul 9, 2021 Direct F1
transaction MYGN Common Stock Sale -$876K -26.7K -10.3% $32.79 233K Jul 9, 2021 Direct F1
transaction MYGN Common Stock Options Exercise $148K +5.6K +2.41% $26.49 238K Jul 9, 2021 Direct F1
transaction MYGN Common Stock Sale -$181K -5.6K -2.35% $32.29 233K Jul 9, 2021 Direct F1
transaction MYGN Common Stock Options Exercise $344K +17.7K +7.61% $19.47 250K Jul 9, 2021 Direct F1
transaction MYGN Common Stock Sale -$574K -17.7K -7.07% $32.47 233K Jul 9, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -17.7K -100% $0.00* 0 Jul 9, 2021 Common Stock 17.7K $19.47 Direct F1, F2
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -26.7K -18.83% $0.00 115K Jul 9, 2021 Common Stock 26.7K $26.49 Direct F1, F2
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -5.6K -4.87% $0.00 110K Jul 9, 2021 Common Stock 5.6K $26.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to this option are fully vested and exercisable.